Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Gene Therapy

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gt.2011.13PMID 21368898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

  2010cited by this paper
• Efficient CNS gene delivery by intravenous injection

  2010cited by this paper
• Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates.

  2010cited by this paper
• Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys

  2009cited by this paper
• HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes.

  2009cited by this paper
• EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO‐ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE‐120 FOR PARKINSON'S DISEASE

  2009cited by this paper
• Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.

  2008cited by this paper
• Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum.

  2008cited by this paper
• Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications.

  2007cited by this paper
• Efficient Gene Transfer via Retrograde Transport in Rodent and Primate Brains Using a Human Immunodeficiency Virus Type 1-Based Vector Pseudotyped with Rabies Virus Glycoprotein

  2007cited by this paper
• Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors

  2007cited by this paper
• Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors

  2007cited by this paper
• Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis

  2006cited by this paper
• Rat Bone Marrow Progenitor Cells Transduced In Situ by rSV40 Vectors Differentiate into Multiple Central Nervous System Cell Lineages

  2006cited by this paper
• Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys

  2006cited by this paper
• Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.

  2006cited by this paper
• Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys

  2006cited by this paper
• Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice

  2006cited by this paper
• Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey Brain

  2006cited by this paper
• Beyond the olfactory bulb: an odotopic map in the forebrain.

  2005cited by this paper
• Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors.

  2004cited by this paper
• Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates

  2004cited by this paper
• Adenoviral Vectors for Gene Replacement Therapy

  2004cited by this paper
• Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.

  2004cited by this paper
• Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.

  2004cited by this paper
• Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.

  2003cited by this paper
• Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.

  2003cited by this paper
• Inhibition of HIV-1 in the Central Nervous System by IFN-α2 Delivered by an SV40 Vector

  2003cited by this paper
• Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.

  2002cited by this paper
• Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration

  2002cited by this paper
• Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector.

  2002cited by this paper
• Generation of recombinant SV40 vectors for gene transfer.

  2001cited by this paper
• X-Linked Vacuolated Myopathy : TNF-α and IFN-γ Expression in Muscle Fibers with MHC Class I on Sarcolemma

  2001cited by this paper
• X-linked vacuolated myopathy : TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma.

  2001cited by this paper
• Viral Vectors for Gene Therapy in Parkinson's Disease

  2001cited by this paper
• Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

  2000cited by this paper
• A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats.

  2000cited by this paper
• Reversal of Pathology in the Entire Brain of Mucopolysaccharidosis Type VII Mice after Lentivirus-Mediated Gene Transfer

  2000cited by this paper
• Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Lentiviral gene transfer to the nonhuman primate brain.

  1999cited by this paper
• Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus

  1999cited by this paper
• Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

  1999cited by this paper
• Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.

  1999cited by this paper
• Adenovirus-Mediated Transgene Expression in Nonhuman Primate Brain

  1999cited by this paper
• Gene therapy using SV40‐derived vectors: What does the future hold?

  1999cited by this paper
• Adeno-Associated Virus Vector-Mediated Transgene Integration into Neurons and Other Nondividing Cell Targets

  1998cited by this paper
• Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume.

  1998cited by this paper
• Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease

  1998cited by this paper
• Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells

  1997cited by this paper
• Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase

  1997cited by this paper
• Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector.

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• SV40 as an effective gene transfer vector in vivo.

  1996cited by this paper
• SV40 mediates stable gene transfer in vivo.

  1996cited by this paper
• Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Expression of Escherichia coli β-Galactosidase and Rat HPRT in the CNS of Macaca mulatta Following Adenoviral Mediated Gene Transfer

  1994cited by this paper
• Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer.

  1994cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper

• Revealing in real-time a multistep assembly mechanism for SV40 virus-like particles

  2020cites this paper
• Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery

  2019cites this paper
• Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40

  2018cites this paper
• Gene Delivery of Antioxidant Enzymes in HIV-1-Associated Neurocognitive Disorder

  2018cites this paper
• Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

  2018cites this paper
• Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies

  2017cites this paper
• Emerging Considerations in Virus-Based Gene Transfer Systems

  2017cites this paper
• Assessment of Apoptosis and Neuronal Loss in Animal Models of HIV-1-Associated Neurocognitive Disorders

  2016cites this paper
• The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?

  2014cites this paper
• Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes

  2014cites this paper
• CNS Gene Therapy Utilizing Intravenously Administered Viral Vectors

  2014cites this paper
• CD11b integrin receptor as a regulator of microglial function and a target for non-viral gene delivery

  2013cites this paper
• HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.

  2012cites this paper
• Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases.

  2012cites this paper
• Alphavirus Vectors for Therapy of Neurological Disorders

  2012cites this paper
• Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications

  2012cites this paper
• Intracisternal rSV40 administration provides effective pan-CNS transgene expression

  2011cites this paper
• Antioxidant Therapy- A Relevant Therapeutic Adjunct For Antiretroviral Therapy In Plwhas In Ghana

  2010cites this paper